Cubist Systematic Strategies, LLC Immunity Bio, Inc. Transaction History

Cubist Systematic Strategies, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$3.23 - $6.17 $184,006 - $351,492	56,968 New	56,968 $305,000
Q1 2023 May 15, 2023	BUY	$1.35 - $4.78 $205,679 - $728,256	152,355 New	152,355 $277,000
Q3 2022 Nov 14, 2022	SELL	$3.65 - $6.43 $206,794 - $364,298	-56,656 Reduced 73.24%	20,700 $103,000
Q2 2022 Aug 15, 2022	SELL	$2.68 - $6.14 $124,743 - $285,792	-46,546 Reduced 37.57%	77,356 $288,000
Q1 2022 May 16, 2022	BUY	$5.05 - $7.53 $530,300 - $790,725	105,010 Added 555.84%	123,902 $695,000
Q4 2021 Feb 14, 2022	SELL	$5.67 - $10.18 $56,756 - $101,901	-10,010 Reduced 34.63%	18,892 $115,000
Q3 2021 Nov 15, 2021	SELL	$9.17 - $14.24 $1.19 Million - $1.85 Million	-129,778 Reduced 81.79%	28,902 $282,000
Q2 2021 Aug 16, 2021	BUY	$13.41 - $22.4 $2.13 Million - $3.55 Million	158,680 New	158,680 $2.27 Million

204

70M

1.64M

1.31M

Ticker IBRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 400,304,000
Market Cap $1.18B
Description
ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.